Format

Send to

Choose Destination
Cancer J. 2010 May-Jun;16(3):235-40. doi: 10.1097/PPO.0b013e3181e075e9.

Treatment of liver-limited metastatic colorectal cancer.

Author information

1
Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. hubbard.joleen@mayo.edu

Abstract

Although liver metastases from colorectal cancer previously conferred a very dismal prognosis, advances in systemic therapy combined with surgical techniques now gives these patients a reasonable chance for cure. Traditional cytoxic chemotherapy combined with biologic agents result in impressive response rates, allowing a portion of patients who were considered unresectable to undergo hepatectomy with curative intent. This review discusses the role of systemic therapy in patients with liver-limited metastatic disease for patients with resectable, potentially resectable and unresectable disease.

PMID:
20526102
DOI:
10.1097/PPO.0b013e3181e075e9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center